Track papers across labs, topics, and trends.
Search papers, labs, and topics across Lattice.
1
0
0
0
QL1706 plus EC was well-tolerated and showed promising anti-tumor activity and survival benefit in first-line treatment for ES-SCLC, and warranted further validation in larger scale phase 3 studies.